Attendee search 

· About Us
Chairman，Mr. Rongguang WU is also the founder of Hongxing Erke , which is one of the most famous sports brands in China. We focus on investing in innovative biotech companies and healthcare funds worldwide. We have an expert team and also seek license-in opportunity of innovative drugs to develop and commercialize in China.

· Investment Cases

Previously, we've invested over 100 million dollars, more than 10 projects worldwide, including VIR Biotechnology, Beijing Genomics institution, GMAX Bio and two Top 10 biomedical funds in America, etc..

· Investment Preference

We don’t have clear limits on the investment scale and the proportion of shares, usually $5 million to $20 million of a single investment. Companies in initial stage to growth stage are all in our consideration. We can lead, co-lead, or join a round that others are leading.

Website：www.hongxingerke.com

天士力

Pharma

RNA(R&D)

CRO based in Shanghai

ophthalmic laser device R&D company

SIRC is specialized in natural drug discovery from Chinese Medicine. It has a TCM data base including 270,000 prescriptions, 9,000 herbs and 50,000 herb-derived compounds. We provide the customized drug discovery based on natural herbs.

for medicine innovation

simcere pharmaceutical group